Screener
Protagonist Therapeutics PTGX Net debt
Discontinued — last reported Q2 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Protagonist Therapeutics’s reported figures.
The source filing: Protagonist Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091123
FAQ
- What is Protagonist Therapeutics's net debt?
- Protagonist Therapeutics (PTGX) reported net debt of -$410.86M in Q2 2026.
- How has Protagonist Therapeutics's net debt changed year-over-year?
- Protagonist Therapeutics's net debt decreased by 161.3% year-over-year, from -$157.26M to -$410.86M.
- What is the long-term trend for Protagonist Therapeutics's net debt?
- Over 5 years (2020 to 2025), Protagonist Therapeutics's net debt has grown at a 1.2% compound annual growth rate (CAGR), from -$111.4M to -$118.07M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Protagonist Therapeutics's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude